ConductScience.org, home

Paper412786

Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Pavlovskis OR and 3 others. Infect Immun, 1977. Cited by 109 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Papers, record 412786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412786

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
PubMed
Journal
Infect Immun
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
3.95
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pavlovskis ORO R
2Pollack MM
3Callahan LT 3rdL T
4Iglewski BHB H

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntitoxinsMajor topic
BurnsMajor topic
Immunity, Maternally-AcquiredMajor topic
Pseudomonas InfectionsMajor topic
Pseudomonas aeruginosaMajor topic
Animals
Exotoxins
Female
Liver
Mice
Sepsis

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
165,205Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity.Can J Microbiol1977https://conductscience.org/library/papers/65205PubMed
268,931Incidence of exotoxin production by Pseudomonas species.Infect Immun1977https://conductscience.org/library/papers/68931PubMed
3188,760Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo.Infect Immun1977https://conductscience.org/library/papers/188760PubMed
4404,244Exotoxin production by clinical isolates of pseudomonas aeruginosa.Infect Immun1977https://conductscience.org/library/papers/404244PubMed
5407,250Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.J Clin Microbiol1977https://conductscience.org/library/papers/407250PubMed
6825,470Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.Infect Immun1976https://conductscience.org/library/papers/825470PubMed
74,370,620Extracellular toxins of Pseudomonas aeruginosa.J Infect Dis1974https://conductscience.org/library/papers/4370620PubMed
8815,443Pseudomonas aeruginosa exotoxin in mice: histopathology and serum enzyme changes.J Infect Dis1976https://conductscience.org/library/papers/815443PubMed
94,200,593Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.J Infect Dis1973https://conductscience.org/library/papers/4200593PubMed
104,200,592Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A.J Infect Dis1973https://conductscience.org/library/papers/4200592PubMed
114,206,027Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis.Infect Immun1974https://conductscience.org/library/papers/4206027PubMed
124,202,883Purification and characterization of Pseudomonas aeruginosa exotoxin.Infect Immun1974https://conductscience.org/library/papers/4202883PubMed
134,624,815Pseudomonas aeruginosa exotoxin: effect on cell cultures.J Infect Dis1972https://conductscience.org/library/papers/4624815PubMed
14166,383NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/166383PubMed
154,959,184The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.J Infect Dis1966https://conductscience.org/library/papers/4959184PubMed
164,968,365Pseudomonas exotoxin shock. A preliminary report of studies in dogs.JAMA1968https://conductscience.org/library/papers/4968365PubMed
17820,647Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.Infect Immun1976https://conductscience.org/library/papers/820647PubMed
18805,812Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.J Infect Dis1975https://conductscience.org/library/papers/805812PubMed

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
25,510,881The prrF-encoded small regulatory RNAs are required for iron homeostasis and virulence of Pseudomonas aeruginosa.Infect Immun2015https://conductscience.org/library/papers/25510881PubMed
24,670,666
"Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa.
Pharmaceuticals (Basel)2014https://conductscience.org/library/papers/24670666PubMed
23,630,954Regulation of Rab5 function during phagocytosis of live Pseudomonas aeruginosa in macrophages.Infect Immun2013https://conductscience.org/library/papers/23630954PubMed
21,219,588
Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio.
Chem Biol Drug Des2011https://conductscience.org/library/papers/21219588PubMed
21,203,470A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.PLoS One2010https://conductscience.org/library/papers/21203470PubMed
19,183,501Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.BMC Microbiol2009https://conductscience.org/library/papers/19183501PubMed
18,098,173Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.Biopolymers2008https://conductscience.org/library/papers/18098173PubMed
17,158,938Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17158938PubMed
11,598,071Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.Infect Immun2001https://conductscience.org/library/papers/11598071PubMed
11,500,471PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.Infect Immun2001https://conductscience.org/library/papers/11500471PubMed
7,591,089Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.Infect Immun1995https://conductscience.org/library/papers/7591089PubMed
7,537,248Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.Infect Immun1995https://conductscience.org/library/papers/7537248PubMed
6,821,202Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.J Clin Microbiol1982https://conductscience.org/library/papers/6821202PubMed
6,807,846Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.Infect Immun1982https://conductscience.org/library/papers/6807846PubMed
6,800,950Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A.Infect Immun1981https://conductscience.org/library/papers/6800950PubMed
6,788,700Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.Infect Immun1981https://conductscience.org/library/papers/6788700PubMed
6,783,532Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.Infect Immun1980https://conductscience.org/library/papers/6783532PubMed
6,775,004Production of alkaline protease by Pseudomonas aeruginosa.J Clin Microbiol1980https://conductscience.org/library/papers/6775004PubMed
6,772,570Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization.Infect Immun1980https://conductscience.org/library/papers/6772570PubMed
6,551,339Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.Infect Immun1983https://conductscience.org/library/papers/6551339PubMed

See all 58 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/412786

GET https://conductscience.org/api/papers/v1/412786/cited_by?page=2